Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebo controlled pilot trial (CANTREAT study).
about
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patientsPathophysiology of Pediatric Multiple Organ Dysfunction Syndrome.Fungal-bacterial interactions and their relevance in health.Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics.Measuring (1,3)-β-D-glucan in tracheal aspirate, bronchoalveolar lavage fluid, and serum for detection of suspected Candida pneumonia in immunocompromised and critically ill patients: a prospective observational study.Impact of selective digestive decontamination on respiratory tract Candida among patients with suspected ventilator-associated pneumonia. A meta-analysis.Focus on infection and sepsis in intensive care patients.Characteristics, Clinical Relevance, and the Role of Echinocandins in Fungal-Bacterial Interactions.Outcomes associated with routine systemic antifungal therapy in critically ill patients with Candida colonization.Antifungal therapy in patients with pulmonary Candida spp. colonization may have no beneficial effectsChoosing Optimal Antifungal Agents To Prevent Fungal Infections in Nonneutropenic Critically Ill Patients: Trial Sequential Analysis, Network Meta-analysis, and Pharmacoeconomic Analysis.Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: reply to Roux and Ricard.
P2860
Q24186457-FAD99272-50F2-4FE2-9287-9C780C3F2325Q33439759-6EA903D4-FCAB-4F24-99C1-90A4496CD6BAQ35738043-39FC7C70-C061-43E1-A0FC-6860DD32CCF2Q35816268-AF822EC4-EF2A-4B05-BD55-3A5BF8689E1AQ36340864-62458077-B6EE-4015-B966-8B889E21676BQ39820715-2EF90A1A-B4F7-4587-9D0B-25E2BA8D3290Q40797788-2E2ED4B5-0168-4688-9B50-61C69443A1CBQ40910127-C9F43C12-7C99-4EDC-BF27-50A4A3A713A7Q41038889-3E848875-8A04-4BC0-B380-639EB6AE0275Q41121456-0A8D466F-95D2-4C5E-AB41-83FD2FCEFD0AQ49379463-1B1D1E3B-5FA4-4F05-ABFD-F96DB5A87FAFQ51696747-381874D9-3A21-489B-A3CC-AD70E79A6084
P2860
Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebo controlled pilot trial (CANTREAT study).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Candida in the respiratory tra ...... pilot trial (CANTREAT study).
@en
Candida in the respiratory tra ...... placebo controlled pilot trial
@nl
type
label
Candida in the respiratory tra ...... pilot trial (CANTREAT study).
@en
Candida in the respiratory tra ...... placebo controlled pilot trial
@nl
prefLabel
Candida in the respiratory tra ...... pilot trial (CANTREAT study).
@en
Candida in the respiratory tra ...... placebo controlled pilot trial
@nl
P2093
P2860
P1476
Candida in the respiratory tra ...... pilot trial (CANTREAT study).
@en
P2093
Coleman Rotstein
Daren Heyland
David Williamson
John Muscedere
Martin Albert
Salmaan Kanji
Xuran Jiang
P2860
P2888
P304
P356
10.1007/S00134-014-3352-2
P577
2014-07-01T00:00:00Z